MALT1 and diffuse large B-cell lymphoma: The MALT1 inhibitor z‐VRPR‐fmk effectively inhibits ABC DLBCL growth in vitro and in vivo, but is presumably unsuitable for clinical applications as a consequence of its large size and relatively poor cell permeability [16, 18].